Title Transkateterska implantacija aortalnog zaliska: transfemoralni i transapikalni pristup
Title (english) Transcatheter aortic valve implantation: transfemoral and transapical approach
Author Marko Gatarić
Mentor Vjekoslav Tomulić (mentor)
Committee member David Gobić (predsjednik povjerenstva)
Committee member Tomislav Jakljević (član povjerenstva)
Committee member Boris Barac (član povjerenstva)
Granter University of Rijeka Faculty of Health Studies Rijeka
Defense date and country 2023-04-27, Croatia
Scientific / art field, discipline and subdiscipline BIOMEDICINE AND HEALTHCARE Clinical Medical Sciences
Abstract Uvod: Aortalna stenoza je najčešći oblik bolesti srčanih zalistaka u razvijenim zemljama, pogađa 3% svjetskog stanovništva starijeg od 65 godina. Standardna metoda liječenja simptomatskog bolesnika je zamjena aortalnog zaliska kirurškim putem. Bolesnici kod kojih je utvđen visok rizik za kiruršku operaciju aortalni zalistak implantira se na minimalno invazivan način, transkateterskim putem.
Cilj istraživanja: Usporedba transfemoralnog pristupa implantacije aortalne valvule naspram transapikalnog. Uspoređivana je bolnička i rana postoperativna smrtnost, komplikacije uslijed zahvata, trajanje hospitalizacije i boravka u jedinici intenzivnog liječenja, sistolička funkcija lijeve klijetke i kvaliteta života bolesnika po NYHA klasifikaciji.
Ispitanici i metode: Istraživanje je provedeno retrospektivno na 99 bolesnika hospitaliziranih u KBC-u Rijeka u periodu od 2015. do 2022. godine. Podaci su se prikupljali iz bolničkog informacijskog sustava IBIS. U istraživanje su bili uključeni samo bolesnici kojima je implantirana aortalna valvula proizvođača Edwards Lifesciences jer se samo ta valvula implantira transfemoralnim i transapikalnim putem.
Rezultati: Prosječna dob ispitanika bila je 81 ± 6,65 godina. Utvrđena je statistički značajna razlika u broju bolesnika između dvije skupine, u transfemoralnoj skupini je sudjelovalo 83 bolesnika, a u transapikalnoj 16 bolesnika, p<0,001. Smrtnost je iznosila 6,06% i nije se bitno razlikovala među skupinama. Nije utvrđena statistički značajna razlika među skupinama u komplikacijama uslijed zahvata ni u sistoličkoj funkciji lijeve klijetke. Trajanje hospitalizacije se bitno razlikovalo među skupinama, transfemoralna skupina je u prosjeku boravila u bolnici 7,32 ± 5,23 dana, a transapikalna 12,43 ± 4,67 dana, p<0,001. NYHA razred se u obje skupine značajno poboljšao nakon TAVI zahvata, a razlike među skupinama nije bilo.
Zaključak: Dobivenim rezultatima ovog istraživanja došlo se do zaključka da osim u trajanju hospitalizacije, nema statistički značajne razlike između TAVI zahvata izvedenog transfemoralnim pristupom naspram transapikalnim pristupom. Trajanje hospitalizacije u prosjeku je značajno kraće kod bolesnika kojima je TAVI zahvat izveden transfemoralnim pristupom.
Abstract (english) Introduction: Aortic stenosis is the most common form of heart valve disease in developed countries, affecting 3% of the world's population over the age of 65. The standard method of treating a symptomatic patient is surgical replacement of the valve. In patients with a high risk for surgery, the valve is implanted in a minimally invasive way, with a transcatheter approach.
Research objective: Comparison of the transfemoral vs. transapical aortic valve implantation approach. The data that were compared were in-hospital and early postoperative mortality, complications due to the procedure, duration of hospitalization and stay in the intensive unit, left ventricular systolic function and patient life quality according to the NYHA classification.
Subjects and methods: The research was conducted retrospectively on 99 patients hospitalized at KBC Rijeka in the period from 2015 to 2022. The data were collected from the hospital information system IBIS. Only patients who were implanted with an aortic valve manufactured by Edwards Lifesciences were included in the study because only their valves are implanted through a transfemoral and transapical approach.
Results: The average age of the subjects was 81 ± 6,65 years. A statistically significant difference was found in the number of patients between the two groups, 83 patients participated in the transfemoral group, and 16 patients in the transapical group, p<0.001. Mortality was 6.06% and did not differ significantly between groups. There was no statistically significant difference between the groups in complications due to procedure or in the systolic function of the left ventricle. The duration of hospitalization differed significantly between the groups, the transfemoral group spent an average of 7,32 ± 5,23 days in the hospital, and the transapical 12,43 ± 4,67 days, p<0.001. The condition of the patients according to the NYHA classification significantly improved in both groups, there was no difference between the groups.
Conclusion: The obtained results of this research led to the conclusion that, apart from the duration of hospitalization, there was no statistically significant difference between the TAVI procedure performed with the transfemoral approach versus the transapical approach. The duration of hospitalization on average is significantly shorter in patients who underwent the TAVI procedure with the transfemoral approach.
Keywords
Aortalna stenoza
TAVI
transapikalni pristup
transfemoralni pristup
Keywords (english)
aortic stenosis
TAVI
transapical approach
transfemoral approach
Language croatian
URN:NBN urn:nbn:hr:184:385519
Study programme Title: Professional study of nursing (Biomedicine and Healthcare; clinical medical sciences) Study programme type: professional Study level: undergraduate Academic / professional title: stručni/a prvostupnik/prvostupnica (baccalaureus/baccalaurea) sestrinstva (stručni/a prvostupnik/prvostupnica (baccalaureus/baccalaurea) sestrinstva)
Type of resource Text
File origin Born digital
Access conditions Open access
Terms of use
Created on 2023-04-15 11:38:04